@article{f10938221032463690a3f71ad5e6dd62,
title = "Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update",
abstract = "ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options.",
author = "{Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Expert Panel} and Giordano, {Sharon H.} and Freedman, {Rachel A.} and Somerfield, {Mark R.} and Mariana Chavez-MacGregor and Comander, {Amy H.} and Zoneddy Dayao and Andrea Eisen and Ragisha Gopalakrishnan and Graff, {Stephanie L.} and Hassett, {Michael J.} and King, {Tari A.} and Lyman, {Gary H.} and Raquel Nunes and Perkins, {Cheryl L.} and Telli, {Melinda L.} and Trudeau, {Maureen E.} and Wolff, {Antonio C.}",
note = "Publisher Copyright: Copyright {\textcopyright} 2022 American Society of Clinical Oncology. All rights reserved.",
year = "2022",
month = jan,
day = "20",
doi = "10.1200/JCO.21.02677",
language = "English (US)",
volume = "40",
pages = "307--309",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "3",
}